Disease-modifying therapies should be stopped in NMOSD patients in remission – Commentary

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1220-1222
Number of pages3
JournalMultiple Sclerosis Journal
Volume25
Issue number9
DOIs
StatePublished - Aug 1 2019

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this